Literature DB >> 14573823

Sodium hydroxide renders the prion protein PrPSc sensitive to proteinase K.

Fabian Käsermann1, Christoph Kempf2,1.   

Abstract

Sodium hydroxide (NaOH) solutions are widely used for the purification of contaminated equipment, as they are known to inactivate a variety of pathogens. However, information about their effect on agents causing transmissible spongiform encephalopathy (TSE) is sparse and contradictory. Scrapie hamster brain homogenate, containing the disease-associated form of the prion protein (PrP(Sc)), was exposed to NaOH. Kinetics studies showed that treatment of brain homogenate with millimolar concentrations of NaOH rapidly abolished the proteinase K-resistant form of the prion protein (PrP(res)). NaOH treatment converted PrP(Sc) into a protease-sensitive form, either in solution or when adsorbed to a metallic surface. If infectivity of TSEs is linked with PrP(res), the results imply that inactivation of TSE occurs more efficiently than currently assumed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14573823     DOI: 10.1099/vir.0.19355-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  7 in total

1.  Prion protein amyloid formation under native-like conditions involves refolding of the C-terminal alpha-helical domain.

Authors:  Nathan J Cobb; Adrian C Apetri; Witold K Surewicz
Journal:  J Biol Chem       Date:  2008-10-17       Impact factor: 5.157

2.  Enzymatic degradation of PrPSc by a protease secreted from Aeropyrum pernix K1.

Authors:  Marko Snajder; Tanja Vilfan; Maja Cernilec; Ruth Rupreht; Mara Popović; Polona Juntes; Vladka Čurin Serbec; Nataša Poklar Ulrih
Journal:  PLoS One       Date:  2012-06-28       Impact factor: 3.240

3.  Diffusion of protease into meat & bone meal for solubility improvement and potential inactivation of the BSE prion.

Authors:  Brian A Coll; Rafael A Garcia; William N Marmer
Journal:  PLoS One       Date:  2007-02-28       Impact factor: 3.240

Review 4.  Pathogen inactivation and removal methods for plasma-derived clotting factor concentrates.

Authors:  Robert Klamroth; Albrecht Gröner; Toby L Simon
Journal:  Transfusion       Date:  2013-09-30       Impact factor: 3.157

5.  Ablation of prion protein immunoreactivity by heating in saturated calcium hydroxide.

Authors:  Justin J Greenlee; Eric M Nicholson; Amir N Hamir; Gary P Noyes; Mark T Holtzapple; Marcus E Kehrli
Journal:  BMC Res Notes       Date:  2008-10-28

6.  Assessing the aggregated probability of entry of a novel prion disease agent into the United Kingdom.

Authors:  Verity Horigan; Paul Gale; Amie Adkin; Timm Konold; Claire Cassar; John Spiropoulos; Louise Kelly
Journal:  Microb Risk Anal       Date:  2020-08-15

Review 7.  Pathogen safety of plasma-derived products - Haemate P/Humate-P.

Authors:  A Gröner
Journal:  Haemophilia       Date:  2008-11       Impact factor: 4.287

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.